Literature DB >> 17852429

Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.

Blagovest Pehlivanov1, Maria Orbetzova.   

Abstract

AIM: Our aim was to investigate the percentage occurrence of different phenotypes of polycystic ovary syndrome (PCOS) in a Bulgarian population, and their clinical, biochemical and hormonal characteristics.
METHODS: The study included 70 women with PCOS, diagnosed according to the European Society of Human Reproduction & Embryology/American Society for Reproductive Medicine criteria. The women were divided into four phenotypes: hyperandrogenism (HA) + oligo-/anovulation (OA) + polycystic ovaries at ultrasound (PCO) (full-blown syndrome, phenotype A); HA + OA (former National Institutes of Health definition, phenotype B); OA + PCO (phenotype C); and HA + PCO (phenotype D). Serum levels of testosterone, immune-reactive insulin, sex hormone-binding globulin, dehydroepiandrosterone sulfate and lipid metabolism parameters were measured. Free androgen index and homeostasis model assessment of insulin resistance were calculated. Body mass index and waist-to-hip ratio were assessed.
RESULTS: The percentages of phenotypes A, B, C and D in a Bulgarian population are 58.6%, 11.4%, 10.0% and 20.0%, respectively. The women with the classical form of PCOS (phenotypes A and B) were more obese, had more strongly expressed hyperandrogenemia, and were more insulin-resistant compared with the women of phenotypes C and D.
CONCLUSION: There is a significant difference in anthropometric, hormonal and metabolic indices between the classical form and the clinical variants of PCOS in the studied Bulgarian population.

Entities:  

Mesh:

Year:  2007        PMID: 17852429     DOI: 10.1080/09513590701536246

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  15 in total

1.  Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome.

Authors:  Mahnaz Ashrafi; Fatemeh Sheikhan; Arezoo Arabipoor; Nicole Rouhana; Roya Hosseini; Zahra Zolfaghari
Journal:  Oman Med J       Date:  2017-05

2.  Is there a Relationship between Serum IGF-1 and Thyroid Nodule, Thyroid or Ovarian Volume in Polycystic Ovarian Syndrome?

Authors:  O Topaloglu; B Evren; M Uzun; S Yologlu; E Guldogan; I Sahin
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

3.  Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome.

Authors:  Nina M Clark; Amanda J Podolski; Eric D Brooks; Donna R Chizen; Roger A Pierson; Denis C Lehotay; Marla E Lujan
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

Review 4.  Oligomenorrhoea in exercising women: a polycystic ovarian syndrome phenotype or distinct entity?

Authors:  Susan Awdishu; Nancy I Williams; Sheila E Laredo; Mary Jane De Souza
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

5.  Comparing classic and newer phenotypes in Greek PCOS women: the prevalence of metabolic syndrome and their association with insulin resistance.

Authors:  V Vaggopoulos; E Trakakis; C Chrelias; P Panagopoulos; G Basios; S Makridima; V D Sioulas; G Simeonides; G Labos; E Boutati; D Kassanos
Journal:  J Endocrinol Invest       Date:  2012-11-27       Impact factor: 4.256

6.  The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study.

Authors:  Mohammed Altigani Abdalla; Harshal Deshmukh; Irfaan Mohammed; Stephen Atkin; Marie Reid; Thozhukat Sathyapalan
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

7.  Phenotype and metabolic disorders in polycystic ovary syndrome.

Authors:  Olgierd Głuszak; Urszula Stopińska-Głuszak; Piotr Glinicki; Renata Kapuścińska; Hanna Snochowska; Wojciech Zgliczyński; Romuald Dębski
Journal:  ISRN Endocrinol       Date:  2012-02-29

8.  Prevalence of metabolic syndrome in four phenotypes of PCOS and its relationship with androgenic components among Iranian women: A cross-sectional study.

Authors:  Narges Zaeemzadeh; Shahideh Jahanian Sadatmahalleh; Saeideh Ziaei; Anoshirvan Kazemnejad; Azadeh Mottaghi; Neda Mohamadzadeh; Maryam Movahedinejad
Journal:  Int J Reprod Biomed       Date:  2020-04-30

9.  Comparison of the Different PCOS Phenotypes Based on Clinical Metabolic, and Hormonal Profile, and their Response to Clomiphene.

Authors:  Garima Sachdeva; Shalini Gainder; Vanita Suri; Naresh Sachdeva; Seema Chopra
Journal:  Indian J Endocrinol Metab       Date:  2019 May-Jun

Review 10.  Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review.

Authors:  Matteo Iervolino; Elisa Lepore; Gianpiero Forte; Antonio Simone Laganà; Giovanni Buzzaccarini; Vittorio Unfer
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.